Murphy & Mullick Capital Management Corp Acquires Shares of 653 Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT)

Murphy & Mullick Capital Management Corp purchased a new position in shares of Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 653 shares of the company’s stock, valued at approximately $26,000.

Innovator IBD Breakout Opportunities ETF Stock Performance

NYSEARCA BOUT opened at $36.18 on Friday. The business has a fifty day moving average price of $38.94 and a 200 day moving average price of $38.74. The company has a market cap of $12.66 million, a P/E ratio of 27.94 and a beta of 0.99. Innovator IBD Breakout Opportunities ETF has a one year low of $32.53 and a one year high of $42.41.

About Innovator IBD Breakout Opportunities ETF

The Innovator IBD Breakout Opportunities ETF (BOUT) is an exchange-traded fund that is based on the IBD Breakout Stocks Total Return index. The fund tracks an index of US-listed stocks that are likely to breakout, as determined by technical analysis. Holdings are weighted by a mix of fundamental and technical factors BOUT was launched on Sep 13, 2018 and is managed by Innovator.